- Home
- DRTS vs JGH Comparison
DRTS vs JGH Comparison
Compare DRTS & JGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRTS
- JGH
- Stock Information
- Founded
- DRTS 2015
- JGH 2014
- Country
- DRTS Israel
- JGH United States
- Employees
- DRTS N/A
- JGH N/A
- Industry
- DRTS Medical/Dental Instruments
- JGH Investment Managers
- Sector
- DRTS Health Care
- JGH Finance
- Exchange
- DRTS Nasdaq
- JGH Nasdaq
- Market Cap
- DRTS 256.2M
- JGH 306.4M
- IPO Year
- DRTS N/A
- JGH N/A
- Fundamental
- Price
- DRTS $3.28
- JGH $13.50
- Analyst Decision
- DRTS Strong Buy
- JGH
- Analyst Count
- DRTS 1
- JGH 0
- Target Price
- DRTS $9.00
- JGH N/A
- AVG Volume (30 Days)
- DRTS 55.6K
- JGH 73.9K
- Earning Date
- DRTS 08-11-2025
- JGH 01-01-0001
- Dividend Yield
- DRTS N/A
- JGH 9.85%
- EPS Growth
- DRTS N/A
- JGH N/A
- EPS
- DRTS N/A
- JGH N/A
- Revenue
- DRTS N/A
- JGH N/A
- Revenue This Year
- DRTS N/A
- JGH N/A
- Revenue Next Year
- DRTS N/A
- JGH N/A
- P/E Ratio
- DRTS N/A
- JGH N/A
- Revenue Growth
- DRTS N/A
- JGH N/A
- 52 Week Low
- DRTS $2.11
- JGH $10.36
- 52 Week High
- DRTS $4.39
- JGH $12.85
- Technical
- Relative Strength Index (RSI)
- DRTS 54.32
- JGH 71.56
- Support Level
- DRTS $3.06
- JGH $13.14
- Resistance Level
- DRTS $3.58
- JGH $13.60
- Average True Range (ATR)
- DRTS 0.19
- JGH 0.08
- MACD
- DRTS 0.02
- JGH 0.03
- Stochastic Oscillator
- DRTS 57.75
- JGH 81.98
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.
About JGH Nuveen Global High Income Fund of Beneficial Interest
Nuveen Global High Income Fund operates as a diversified closed-end management investment company. The fund's investment objective is to provide a high level of current income. Its securities include U.S. high-yield bonds; non-U.S. high-yield bonds from developed and emerging markets; and other income-producing investments such as preferred and convertible securities.